These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry? Verhallen PF; Bevers EM; Comfurius P; Zwaal RF Biochim Biophys Acta; 1987 Sep; 903(1):206-17. PubMed ID: 2820487 [TBL] [Abstract][Full Text] [Related]
3. Development of procoagulant binding sites on the platelet surface. Bevers EM; Rosing J; Zwaal RF Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation. Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237 [TBL] [Abstract][Full Text] [Related]
5. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Comfurius P; Senden JM; Tilly RH; Schroit AJ; Bevers EM; Zwaal RF Biochim Biophys Acta; 1990 Jul; 1026(2):153-60. PubMed ID: 2116169 [TBL] [Abstract][Full Text] [Related]
6. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Dachary-Prigent J; Pasquet JM; Freyssinet JM; Nurden AT Biochemistry; 1995 Sep; 34(36):11625-34. PubMed ID: 7547894 [TBL] [Abstract][Full Text] [Related]
8. Loss of phospholipid asymmetry in dilauroylphosphatidylcholine induced plasma membrane vesicles from human platelets. Bevers EM; Verhallen PF; Linskens WM; Comfurius P; Zwaal RF Biochim Biophys Acta; 1987 Sep; 903(1):197-205. PubMed ID: 3651453 [TBL] [Abstract][Full Text] [Related]
9. Interaction between phosphatidylserine and the isolated cytoskeleton of human blood platelets. Comfurius P; Bevers EM; Zwaal RF Biochim Biophys Acta; 1989 Aug; 983(2):212-6. PubMed ID: 2547447 [TBL] [Abstract][Full Text] [Related]
10. The involvement of cytoskeleton in the regulation of transbilayer movement of phospholipids in human blood platelets. Comfurius P; Bevers EM; Zwaal RF Biochim Biophys Acta; 1985 Apr; 815(1):143-8. PubMed ID: 2985115 [TBL] [Abstract][Full Text] [Related]
11. Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. Franck PF; Bevers EM; Lubin BH; Comfurius P; Chiu DT; Op den Kamp JA; Zwaal RF; van Deenen LL; Roelofsen B J Clin Invest; 1985 Jan; 75(1):183-90. PubMed ID: 3965502 [TBL] [Abstract][Full Text] [Related]
12. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Wiedmer T; Shattil SJ; Cunningham M; Sims PJ Biochemistry; 1990 Jan; 29(3):623-32. PubMed ID: 2159784 [TBL] [Abstract][Full Text] [Related]
13. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. Fox JE; Austin CD; Reynolds CC; Steffen PK J Biol Chem; 1991 Jul; 266(20):13289-95. PubMed ID: 2071604 [TBL] [Abstract][Full Text] [Related]
14. Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen. Pasquet JM; Dachary-Prigent J; Nurden AT Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):591-9. PubMed ID: 9677317 [TBL] [Abstract][Full Text] [Related]
16. Variability in platelet procoagulant activity in healthy volunteers. Sumner WT; Monroe DM; Hoffman M Thromb Res; 1996 Mar; 81(5):533-43. PubMed ID: 8907312 [TBL] [Abstract][Full Text] [Related]
17. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Williamson P; Bevers EM; Smeets EF; Comfurius P; Schlegel RA; Zwaal RF Biochemistry; 1995 Aug; 34(33):10448-55. PubMed ID: 7654698 [TBL] [Abstract][Full Text] [Related]
18. Impaired Ca2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: a study using an inhibitor for scramblase that mimics the defect in Scott syndrome. Dekkers DW; Comfurius P; Vuist WM; Billheimer JT; Dicker I; Weiss HJ; Zwaal RF; Bevers EM Blood; 1998 Mar; 91(6):2133-8. PubMed ID: 9490700 [TBL] [Abstract][Full Text] [Related]
19. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity. Kim JE; Han M; Hanl KS; Kim HK Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386 [TBL] [Abstract][Full Text] [Related]
20. Platelet prothrombinase in health and disease. Crook M Blood Coagul Fibrinolysis; 1990 Jun; 1(2):167-74. PubMed ID: 2130928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]